-+ 0.00%
-+ 0.00%
-+ 0.00%

Santen Pharmaceutical sets a self-stock acquisition limit of 35 billion yen, 5.0% of the issued shares.

NIKKEI QUICK·11/05/2026 06:39:04

Please log in to view news